According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM) is $36.85 M. In 2022 the company made a revenue of $26.58 M an increase over the years 2021 revenue that were of $0.04 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $36.85 M | 38.65% |
2022 | $26.58 M | 60311.36% |
2021 | $0.04 M | -94.69% |
2020 | $0.82 M | -98.03% |
2019 | $42.12 M | 297.57% |
2018 | $10.59 M | -39.61% |
2017 | $17.54 M | -30.29% |
2016 | $25.17 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |